ISDA

Deposition Date 2011-09-16

Release Date 2011-10-12

Last Version Date 2024-11-20

Entry Detail

PDB ID:

3TU7

Keywords:

HYDROLASE/HYDROLASE INHIBITOR

Title:

Human alpha-thrombin complexed with N-(methylsulfonyl)-D-phenylalanyl-N-((1-carbamimidoyl-4-piperidinyl)methyl)-l-prolinamide (BMS-189664)

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)
Hirudo medicinalis (Taxon ID: 6421)

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.49 Å

R-Value Free:

0.22

R-Value Work:

0.15

R-Value Observed:

0.16

Space Group:

P 21 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Prothrombin
Gene (Uniprot):F2
Chain IDs:B (auth: H)
Chain Length:259
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P00734 Pfam ID:PF00089, PF09396 EC:3.4.21.5

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Hirudin variant-2
Chain IDs:C (auth: I)
Chain Length:12
Number of Molecules:1
Biological Source:Hirudo medicinalis

UniProt ID:P01050

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Prothrombin
Gene (Uniprot):F2
Chain IDs:A (auth: L)
Chain Length:36
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P00734 Pfam ID:PF00089, PF09396 EC:3.4.21.5

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
PTR	C	TYR	O-PHOSPHOTYROSINE

Ligand Molecules

0BM

Peptide-like Molecules

PRD_000811

Primary Citation

Molecular design and structure-activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664.

Das, J, Kimball, S.D, Hall, S.E, Han, W.C, Iwanowicz, E, Lin, J, Moquin, R.V, Reid, J.A, Sack, J.S, Malley, M.F, Chang, C.Y, Chong, S, Wang-Iverson, D.B, Roberts, D.G, Seiler, S.M, Schumacher, W.A, Ogletree, M.L.Show

Bioorg.Med.Chem.Lett. 12 45 49 (2002)

PMID: 11738570

Abstact

A series of structurally novel small molecule inhibitors of human alpha-thrombin was prepared to elucidate their structure-activity relationships (SARs), selectivity and activity in vivo. BMS-189664 (3) is identified as a potent, selective, and orally active reversible inhibitor of human alpha-thrombin which is efficacious in vivo in a mouse lethality model, and at inhibiting both arterial and venous thrombosis in cynomolgus monkey models.

Legend

Protein

Chemical

Disease

Primary Citation of related structures